PTEN HAMARTOMA TUMOUR SYNDROME
Stefan Aretz
Institute of Human Genetics
Center for Hereditary Tumour Syndromes
University Hospital Bonn
Germany
Hereditary Cancer Genetics, Lugano, 26.4.2019
DISCLOSURE OF INTEREST
I have no conflict of interest to declare
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
PTEN HAMARTOMA TUMOR SYNDROME (PHTS)
Cowden
syndrome
(CS)
Bannayan-
Riley-Ruvalcaba
syndrome
(BRRS)
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
CAUSATIVE GENES
OMIMOnline Mendelian Inheritance in Man®
An Online Catalog of Human Genes and Genetic Disorders
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
*
* Germline KLLN promoter hypermethylation
Multigene panel testing
CS: TUMOUR SPECTRUM
• Mucocutaneous lesions (99%)
• Hamartomatous intestinal polyps (60-90%)
• Breast cancer
• Non-medullary thyroid cancer
• Endometrial cancer
• Adult cerebellar dysplastic gangliocytoma(Lhermitte-Duclos-Disease – LDD)
• Renal cell carcinoma
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
CS - MUCOCUTANEOUS LESIONS
trichilemmomaspapillomatous papules
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
POLYP HISTOLOGY
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
GANGLIONEUROMATOUS POLYPOSIS (GP)
• Very rare disorder
• Ganglioneuromas:
• benign neuroectodermal tumor
• originate from sympathetic nerve system
• Composed of ganglion cells, Schwann
cells, connective tissue, nerve fibers
• Malignant transformation of
ganglioneuromas unknown
• CS, MEN2b or NF1
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
INTERNATIONAL COWDEN CONSORTIUM
CLINICAL DIAGNOSTIC CRITERIA
Blumenthal, EJHG 2008
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
GeneReviews: www.ncbi.nlm.nih.gov/gtr/
NCCN: www.nccn.org
BANNAYAN-RILEY-RUVALCABA SYNDROME (BRRS)
Subcutaneous tumour
Erkek et al., Dermatopathology 2005
Lipomas Penile freckling
Diagnosis: no consensus criteria Based on presence of cardinal features
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
BANNAYAN-RILEY-RUVALCABA SYNDROME (BRRS)
Subcutaneous tumour
Erkek et al., Dermatopathology 2005
Lipomas Penile freckling
• Macrocephaly
• Developmental delay
• Pigmented macules of the glans penis
• Lipomas
• Intestinal hamartomatous polyposis
Diagnosis: no consensus criteria Based on presence of cardinal features
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
CRANIOFACIAL DYSMORPHIC FEATURES
Parisi et al., JMG 2001; Merks et al., JMG 2003
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
BANNAYAN-RILEY-RUVALCABA SYNDROME (BRRS)
CFC 64 cm
CFC 64 cm
CFC 62 cmIII:1
II:4II:3
I:1 I:2
II:1 II:2
Reutter et al. 2009
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
PEDIATRIC CLINICAL CRITERIA PTEN SCREENING
Tan et al., AJHG 2011
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
PROTEUS SYNDROME (PS) / PROTEUS-LIKE SYNDROME
• complex, highly variable disorder
• progressive segmental or patchy overgrowth / disfigurement (skeleton, skin, adipose, central nervous systems)
• Modest or no manifestations at birth, rapid progresses beginning in toddler period till childhood
• Cerebriform connective tissue nevi (CCTN)
• caused by somatic mosaicism for specific de novo pathogenic variant c.49G>A in AKT1
• Mosaic distribution of lesions
• Sporadic occurrence
• Progressive course
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
JUVENILE POLYPOSIS OF INFANCY
◆ Severe course
early-onset, rectal bleeding, anemia, hypoproteinemia, diarrhea,
abdominal pain, develomental delay
◆ Mikrodeletion syndrome 10q22-q23 (BMPR1A + PTEN)
◆ Symptoms of both JPS and BRRS / PHTS
◆ So far sporadic cases only
◆ Sub-colectomy, mTOR inhibitors (Sirolimus)
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
SURVEILLANCE CS
Blumenthal, EJHG 2008
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019
PHTS: SUMMARY AND CONCLUSIONS
• Multi-system disorder with broad tumour spectrum
and several differential diagnoses
• Clinical diagnosis often challenging, many families
probably remain undiagnosed
• Might be genetically heterogeneous
• Multidisciplinary team, specialised centres
• Research tasks: more sensitive and more simple
clinical criteria
Aretz – Institute of Human Genetics Bonn PTEN Hamartoma Tumour Syndrome Lugano, 26.04.2019